Evidence map›Paper›PMID 41079470›Full record

ReviewThe Malaysian journal of medical sciences : MJMS2025

Pharmacist-Led Patient Education in Secondary Stroke Prevention: A Systematic Review.

Daniek Viviandhari, Tri Murti Andayani, Paryono, Martina Sinta Kristanti

Abstract readReview
In one paragraph

Review in The Malaysian journal of medical sciences : MJMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniek ViviandhariFaculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Tri Murti AndayaniFaculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
ParyonoFaculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Martina Sinta KristantiFaculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recurrence rate of stroke, particularly ischaemic stroke, is considered high, which highlights the importance of secondary stroke prevention. Pharmacists are becoming increasingly involved in poststroke care. Ease of public access to community pharmacists provides opportunities for pharmacists to educate patients about the significance of secondary stroke prevention. The literature outlining comprehensive educational materials for stroke patients to prevent secondary stroke is still limited. This review aimed to obtain the details of the educational material presented by the pharmacist and to determine whether it led to positive outcomes-a comprehensive search involved PubMed, Scopus, Science Direct, and Cochrane Library databases. The Joanna Briggs Institute's (JBI) critical appraisal techniques were utilised to analyse the quality assessment for all study categories. As many as 12 studies were deemed eligible for inclusion. There are seven main categories under which information on secondary stroke prevention education is presented: modifiable risk factors, medication therapy management (MTM), medication adherence, cardiovascular risk factors, stroke (disease state), patient engagement, and quality of life. Pharmacists, mostly in community settings, play an important role in managing stroke risk factors (blood pressure, low-density lipoprotein [LDL], and A1c), promoting medication adherence, preventing hospital readmissions, increasing the level of knowledge, and enhancing patient satisfaction, which showed a favourable effect on preventing stroke recurrence following the pharmacist's educational intervention.

Indexed as

patient educationpharmacist’s interventionrecurrentsecondary preventionstroke

Identifiers

PMID41079470
PMCPMC12513504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.